KetamineHQ

PHQ-9 Depression Test

The PHQ-9 (Patient Health Questionnaire-9) is the standard depression screening used in clinics worldwide. Nine questions, about two minutes, scored instantly with the same severity bands your doctor uses. Your answers never leave your browser.

This is a screening tool, not a diagnosis. Only a licensed clinician can diagnose depression. If you're in crisis, call or text 988 (U.S.) now.
Question 1 of 9

Over the last 2 weeks, how often have you been bothered by...

Little interest or pleasure in doing things

About the PHQ-9

The PHQ-9 was developed by Drs. Robert Spitzer, Janet Williams, and Kurt Kroenke and is in the public domain. It asks about the nine diagnostic criteria for major depression over the past two weeks and is widely used both for initial screening and for tracking symptoms during treatment — including ketamine therapy, where clinics typically administer it before each session to measure response.

If your score is high and you've already tried two or more antidepressants without adequate relief, you may fit the profile clinicians call treatment-resistant depression — the area where ketamine and Spravato have the strongest evidence. Learn what treatment looks like or find a clinic near you. Also see our GAD-7 anxiety screening.